Bristol-Myers Squibb (US)

Despite consolidation in the drug industry, Bristol-Myers Squibb has so far stayed on the sidelines, waiting to make its move and quietly sharpening its focus on the pharmaceutical sector. Once the world's #1 drug company, it has steadily been pushed down the rankings by mergers or aggressive growth among its competitors. During the 1990s, it sold off several of its non-core lines, followed in 2001 by its central Clairol business (to Procter & Gamble) as well as half of its medical devices portfolio, in order to concentrate on medicines. Several other non-core units were sold in 2008 and 2009. As a result of this restructuring, BMS is now widely regarded as a likely takeover target. The group entered tentative merger negotiations in 2007 with Sanofi-Aventis, the developer of its best-selling product, Plavix. No agreement has yet been reached, but the two businesses are favourites to combine at some point in the future. Advertising Age estimated global measured advertising expenditure of $419m in 2007, making BMS the world's #84 advertiser.

Click here to access the Adbrands profile (subscribers only); or subscribe to Adbrands.net here. Adbrands Company Profiles provide a detailed analysis of the history and current operations of leading advertisers, agencies and brands worldwide, and include a critical summary which identifies key strengths and weaknesses. Adbrands Account Assignments tracks account management for the world's leading brands and companies, including details of which advertising agency handles which accounts in which countries for major markets.

Advertising: Which agencies handle advertising for Bristol-Myers Squibb? The searchable account assignments database is available to full subscribers to Adbrands.net premium services. Click here for subscription information.

Competitors: See Pharmaceutical Sector index for other companies

Subscribers may access the following website links:

Bristol-Myers Squibb website

Plavix	Enfamil
Abilify	Mead Johnson Nutritionals
Sprycel	Erbitux
Ixempra	Sustiva
Avapro	Pravachol
Reyataz	Taxol
Atripla	Coumadin

Bristol-Myers Squibb Worldwide

Click HERE to subscribe to Adbrands.net and access the profile and website links